TEZCAT Biologics

TEZCAT is developing a biologics-based therapeutic approach to treat mutant Ras cancers, such as colorectal cancer.   TEZCAT team: CEO – Alex Efron CSO – Craig Ramirez, Ph.D. Ops. Mgr – Andy Hauser, Ph.D.

Read More

Orthomedex

Orthomedex is working on implants that address the unmet fixation and infection control needs of the orthopedic surgeon.   Team: Jim Walls, Founder and CEO David Sutton, VP Engineering    

Read More

Mission Biomedical Scientific

Mission Biomedical Scientific is developing a completely new wearable metabolism monitoring device that provides continuous real time measurements of an individual’s caloric expenditure.   Mission Biomedical Scientific Team: Frank J. Swenson PhD., CEO Andrew Lightner, Financial Analyst 

Read More

Vesselon

Vesselon, Inc. is developing novel therapeutic immuno-oncology complexes that are protected in circulation and actively targeted to tumors using an FDA approved lipid microsphere drug as the backbone of its encapsulated drug/drug platform technology. Furthermore, the complexes are formed at the time of administration (rather than at the drug manufacturing stage) enabling the creation of…

Read More

b2d2

b2d2 is a biotechnology company currently developing two medical diagnostic products and an associated web-based application in to an integrated platform by which to accurately, objectively and seamlessly diagnose and treat concussed individuals. b2d2 Team: Barry Kosofsky, MD, PhD  

Read More

AlloMek

AlloMek is working on a small molecule based therapeutics for rare diseases.   AlloMek Team: Uday Khire, Ph.D. MBA Co-Founder and CEO    

Read More

Shoreline Biome

Shoreline Biome is a start-up company developing microbiome assay kits and analysis software.   Shoreline Biome Team: Thomas Jarvie, PhD. – CEO & Co-founder  

Read More

myReLeaf

A drug-free device providing immediate relief for moments of distress, anxiousness, and stress by regulating the users’ breathing patterns and stimulating their senses. Team: Adi Wallach – Co-Founder, CEO Dr. Orna Levin MD, Co-Founder, President Dr. Avner Wallach P.hD., Co-Founder, CTO

Read More

Lambda Vision, Inc.

LambdaVision, Inc. is commercializing a retinal implant to restore vision for the millions of patients suffering from retinitis pigmentosa (RP) and age-related macular degeneration (AMD).   LambdaVision, Inc. Team: Nicole L. Wagner, PhD, CEO Jordan A. Greco, PhD, CSO  

Read More

SOLaware TM

SOLaware™ Technologies division, a fully owned subsidiary of Vanessa Research, Inc. (VRI), has developed a sun safety education system, called SOLaware™ Display to raising real-time awareness about sun exposure through digital technology.   SOLaware TM Team: Ferenc Fazekas, MBA      

Read More